These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9308268)

  • 1. Self-hypnosis training as an adjunctive treatment in the management of pain associated with sickle cell disease.
    Dinges DF; Whitehouse WG; Orne EC; Bloom PB; Carlin MM; Bauer NK; Gillen KA; Shapiro BS; Ohene-Frempong K; Dampier C; Orne MT
    Int J Clin Exp Hypn; 1997 Oct; 45(4):417-32. PubMed ID: 9308268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypnotically induced pain control in sickle cell anemia.
    Zeltzer L; Dash J; Holland JP
    Pediatrics; 1979 Oct; 64(4):533-6. PubMed ID: 492819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary hyperparathyroidism mimicking vaso-occlusive crises in sickle cell disease.
    Krishnamoorthy P; Alyaarubi S; Abish S; Gale M; Albuquerque P; Jabado N
    Pediatrics; 2006 Aug; 118(2):e537-9. PubMed ID: 16882790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of adenotonsillectomy in reducing obstructive sleep apnea, cerebrovascular ischemia, vaso-occlusive pain, and ACS episodes in pediatric sickle cell disease.
    Tripathi A; Jerrell JM; Stallworth JR
    Ann Hematol; 2011 Feb; 90(2):145-50. PubMed ID: 20714723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of hydroxyurea in reducing the frequency of pain episodes and hospitalization in pediatric sickle cell disease.
    Stallworth JR; Jerrell JM; Tripathi A
    Am J Hematol; 2010 Oct; 85(10):795-7. PubMed ID: 20645429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-regulation and assessment approaches for vaso-occlusive pain management for pediatric sickle cell anemia patients.
    Hall H; Chiarucci K; Berman B
    Int J Psychosom; 1992; 39(1-4):28-33. PubMed ID: 1428615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult emergency department patients with sickle cell pain crisis: a learning collaborative model to improve analgesic management.
    Tanabe P; Artz N; Mark Courtney D; Martinovich Z; Weiss KB; Zvirbulis E; Hafner JW
    Acad Emerg Med; 2010 Apr; 17(4):399-407. PubMed ID: 20370779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pain management in children and adolescents with sickle cell disease.
    Jerrell JM; Tripathi A; Stallworth JR
    Am J Hematol; 2011 Jan; 86(1):82-4. PubMed ID: 20949441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of handheld wireless technology for a home-based sickle cell pain management protocol.
    McClellan CB; Schatz JC; Puffer E; Sanchez CE; Stancil MT; Roberts CW
    J Pediatr Psychol; 2009 Jun; 34(5):564-73. PubMed ID: 19029141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidural analgesia in the management of severe vaso-occlusive sickle cell crisis.
    Yaster M; Tobin JR; Billett C; Casella JF; Dover G
    Pediatrics; 1994 Feb; 93(2):310-5. PubMed ID: 8121746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid selection during sickle cell pain crisis and its impact on the development of acute chest syndrome.
    Buchanan ID; Woodward M; Reed GW
    Pediatr Blood Cancer; 2005 Oct; 45(5):716-24. PubMed ID: 15926170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pain among children and adolescents: restrictions in daily living and triggering factors.
    Roth-Isigkeit A; Thyen U; Stöven H; Schwarzenberger J; Schmucker P
    Pediatrics; 2005 Feb; 115(2):e152-62. PubMed ID: 15687423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of supportive-expressive group therapy on pain in women with metastatic breast cancer.
    Butler LD; Koopman C; Neri E; Giese-Davis J; Palesh O; Thorne-Yocam KA; Dimiceli S; Chen XH; Fobair P; Kraemer HC; Spiegel D
    Health Psychol; 2009 Sep; 28(5):579-87. PubMed ID: 19751084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease, a randomized controlled trial.
    van Beers EJ; van Tuijn CF; Nieuwkerk PT; Friederich PW; Vranken JH; Biemond BJ
    Am J Hematol; 2007 Nov; 82(11):955-60. PubMed ID: 17617790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current psychological approaches to the management of chronic pain.
    Molton IR; Graham C; Stoelb BL; Jensen MP
    Curr Opin Anaesthesiol; 2007 Oct; 20(5):485-9. PubMed ID: 17873602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of uncomplicated vaso-occlusive crises in children with sickle cell disease in a day hospital.
    Raphael JL; Kamdar A; Beavers MB; Mahoney DH; Mueller BU
    Pediatr Blood Cancer; 2008 Jul; 51(1):82-5. PubMed ID: 18383165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical hypnosis versus cognitive behavioral training for pain management with pediatric cancer patients undergoing bone marrow aspirations.
    Liossi C; Hatira P
    Int J Clin Exp Hypn; 1999 Apr; 47(2):104-16. PubMed ID: 10208073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pain in sickle cell disease. Rates and risk factors.
    Platt OS; Thorington BD; Brambilla DJ; Milner PF; Rosse WF; Vichinsky E; Kinney TR
    N Engl J Med; 1991 Jul; 325(1):11-6. PubMed ID: 1710777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of nalbuphine as a parenteral analgesic for the treatment of painful episodes in children with sickle cell disease.
    Woods GM; Parson PM; Strickland DK
    J Assoc Acad Minor Phys; 1990; 1(3):90-2. PubMed ID: 2136623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose intravenous methylprednisolone therapy for pain in children and adolescents with sickle cell disease.
    Griffin TC; McIntire D; Buchanan GR
    N Engl J Med; 1994 Mar; 330(11):733-7. PubMed ID: 8107739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.